Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Jan 19, 2021 2:00pm
116 Views
Post# 32327730

OTC, Frankfurt Exchange, the TSX and Thrm

OTC, Frankfurt Exchange, the TSX and Thrm

Thrm finished up at $.71 CAD on the Frankfurt Exchange and sits around the same on the OTC. We should expect nothing less on the TSX ...and if history is of any consequence, maybe a little higher.

Considering that it's sitting at 10x the sp it fell to after the NR in the summer that really put the idea of CoviSafe into the public arena, this is pretty good. Vaccines aren't arriving as scheduled, covid cases continue to rise and at any one time, somewhere in the country there's an area in lockdown. 

Thrm will level off to a sustainably, reasonable level .....and be ready to take off again. The next time, far more permanently.

GLTA!

<< Previous
Bullboard Posts
Next >>